Toroso Investments, LLC Viking Therapeutics, Inc. Transaction History

Toroso Investments, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$49.84 - $70.47 $566,282 - $800,680	11,362 Added 296.81%	15,190 $961,000
Q2 2024 Aug 14, 2024	SELL	$47.39 - $80.2 $1.19 Million - $2.01 Million	-25,045 Reduced 86.74%	3,828 $202,000
Q1 2024 May 15, 2024	BUY	$17.4 - $94.5 $502,390 - $2.73 Million	28,873 New	28,873 $2.37 Million

471

66.4M

5.88M

3.83M

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $2.34B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Toroso Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Toroso Investments, LLC with notifications on news.